265 related articles for article (PubMed ID: 21103830)
21. Acne inversa successfully treated with infliximab.
von Preussen AC; Flux K; Hartschuh W; Hartmann M
Int J Dermatol; 2012 Aug; 51(8):1011-3. PubMed ID: 21470216
[No Abstract] [Full Text] [Related]
22. Hidradenitis suppurativa responding to treatment with infliximab.
Lasocki A; Sinclair R; Foley P; Saunders H
Australas J Dermatol; 2010 Aug; 51(3):186-90. PubMed ID: 20695857
[TBL] [Abstract][Full Text] [Related]
23. Treatment of hidradenitis suppurativa with infliximab.
Torres T; Selores M
An Bras Dermatol; 2010; 85(4):576. PubMed ID: 20944927
[No Abstract] [Full Text] [Related]
24. Successful treatment of hidradenitis suppurativa with infliximab in a patient who failed to respond to etanercept.
Poulin Y
J Cutan Med Surg; 2009; 13(4):221-5. PubMed ID: 19706231
[TBL] [Abstract][Full Text] [Related]
25. Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: a randomized, double-blind, placebo-controlled crossover trial.
Grant A; Gonzalez T; Montgomery MO; Cardenas V; Kerdel FA
J Am Acad Dermatol; 2010 Feb; 62(2):205-17. PubMed ID: 20115947
[TBL] [Abstract][Full Text] [Related]
26. Review and expert opinion on prevention and treatment of infliximab-related infusion reactions.
Lecluse LL; Piskin G; Mekkes JR; Bos JD; de Rie MA
Br J Dermatol; 2008 Sep; 159(3):527-36. PubMed ID: 18627374
[TBL] [Abstract][Full Text] [Related]
27. Effective long-term control of refractory hidradenitis suppurativa with adalimumab after failure of conventional therapy.
Arenbergerova M; Gkalpakiotis S; Arenberger P
Int J Dermatol; 2010 Dec; 49(12):1445-9. PubMed ID: 21091684
[TBL] [Abstract][Full Text] [Related]
28. New-onset polyarthritis during successful treatment of hidradenitis suppurativa with infliximab.
van Rappard DC; Mooij JE; Baeten DL; Mekkes JR
Br J Dermatol; 2011 Jul; 165(1):194-8. PubMed ID: 21428974
[TBL] [Abstract][Full Text] [Related]
29. Variable response of hidradenitis suppurativa to infliximab in four patients.
Usmani N; Clayton TH; Everett S; Goodfield MD
Clin Exp Dermatol; 2007 Mar; 32(2):204-5. PubMed ID: 17342798
[No Abstract] [Full Text] [Related]
30. Is there a role for infliximab in the current therapy of hidradenitis suppurativa? A report of three treated cases.
Moschella SL
Int J Dermatol; 2007 Dec; 46(12):1287-91. PubMed ID: 18173525
[TBL] [Abstract][Full Text] [Related]
31. Pharmacologic interventions for hidradenitis suppurativa: what does the evidence say?
Alhusayen R; Shear NH
Am J Clin Dermatol; 2012 Oct; 13(5):283-91. PubMed ID: 22676319
[TBL] [Abstract][Full Text] [Related]
32. The off-label treatment of severe hidradenitis suppurativa with TNF-α inhibitors: a systematic review.
van Rappard DC; Limpens J; Mekkes JR
J Dermatolog Treat; 2013 Oct; 24(5):392-404. PubMed ID: 22397574
[TBL] [Abstract][Full Text] [Related]
33. Management of hidradenitis suppurativa with biological therapy: report of four cases and review of the literature.
Bahillo Monné C; Honorato Guerra S; Schoendorff Ortega C; Gargallo Quintero AB
Dermatology; 2014; 229(4):279-87. PubMed ID: 25472035
[TBL] [Abstract][Full Text] [Related]
34. Update on TNF Inhibitors in Dermatology.
Sobell JM
Semin Cutan Med Surg; 2016 Jun; 35(6 Suppl):S104-6. PubMed ID: 27537073
[TBL] [Abstract][Full Text] [Related]
35. Etanercept: effective in the management of hidradenitis suppurativa.
Cusack C; Buckley C
Br J Dermatol; 2006 Apr; 154(4):726-9. PubMed ID: 16536817
[TBL] [Abstract][Full Text] [Related]
36. Current and emerging nonsurgical treatment options for hidradenitis suppurativa.
Kerdel FA
Semin Cutan Med Surg; 2014 Jun; 33(3 Suppl):S57-9. PubMed ID: 25188460
[TBL] [Abstract][Full Text] [Related]
37. Biologic drugs for the treatment of hidradenitis suppurativa: an evidence-based review.
Shuja F; Chan CS; Rosen T
Dermatol Clin; 2010 Jul; 28(3):511-21, 523-4; quiz 522-3. PubMed ID: 20510761
[TBL] [Abstract][Full Text] [Related]
38. [Fatal pneumococcal sepsis in patient with hidradenitis suppurative treated with infliximab].
Benítez-Macías JF; García-Gil D; Brun-Romero FM
Med Clin (Barc); 2008 Dec; 131(20):799. PubMed ID: 19094888
[No Abstract] [Full Text] [Related]
39. [Treatment options in severe hidradenitis suppurativa].
Mooij JE; van't Oost L; Leenarts MF; Mekkes JR
Ned Tijdschr Geneeskd; 2011; 155():A1912. PubMed ID: 21426594
[TBL] [Abstract][Full Text] [Related]
40. Interleukin 6 and high-sensitivity C-reactive protein are potential predictive markers of response to infliximab in hidradenitis suppurativa.
Montaudié H; Seitz-Polski B; Cornille A; Benzaken S; Lacour JP; Passeron T
J Am Acad Dermatol; 2017 Jan; 76(1):156-158. PubMed ID: 27986139
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
